1. Stafstrom CE. The Epilepsies.

Dalam: David RB, Bodensteiner J B,

Mandelbaum DE, Olson B, penyunting. Clinical Pediatric Neurology.
Edisi ke-3. New York: Demos Medical; 2009.h.151-86.
2. Berh AT, Berkovic SF, Brodie MJ , Buchhalter J , Glauser TA, Mathern
GM, dkk. Revised terminology and concepts for organization of
seizures and epilepsies: Report of the ILAE Commission on
Classification and Terminology, 20052009. Epilepsia. 2010; 51:676
85.
3. Heilbroner, Peter L, Castaneda, Glenn Y. Seizures, epilepsy, and
related disorders. Dalam: Heilbroner, Peter L, Castaneda, Glenn Y,
penyunting. Pediatric Neurology: Essentials for General Practice.
Edisi ke-1. New York: Lippincott Williams & Wilkins; 2007.h.149-87.
4. Panayiotopolous CP. Clinical aspects of the diagnosis of epileptic
seizures and epileptic syndromes. Dalam: Panayiotopolous CP ,
penyunting. The Epilepsies Seizures, Syndromes and Management.
Edisi ke-1. UK: Bladon medical publishing; 2005.h.1-25.
5. Teleanu R, Matei M, Sandu M, Nita S. Valproate induced subclinical
hypothyroidism in children with epilepsy. Romanian J of neurol.
2013;12:183-4
6. Kim SH, Chung HR, Kim H, Lim BC, Chae J H, Kim KJ , dkk. Subclinical
hypothyroidism during valproate acid therapy in children and
adolescents with epilepsy. Child Neurol. 2012;27:594-7.
7. Mcdermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid
failure and should be treated. J Clin Endocrinol Metab. 2001;86:455-
90.
8. Sahu J K, Gulati S, Kabra M, Arya R, Sharma R, Gupta N, dkk.
Evaluation of subclinical ambulatory children with controlled epilepsy
on valproate monotherapy. J Child Neurol. 2012;5:594-7.
9. Kaplowitz PB. Subclinical hypothyroidism in children: Normal variation
or sign of a failing thyroid gland?. Int J of Ped Endocrinol. 2010; 20:1-8
10. Mikati MA, Tarabay H, Khalil A, Rahi AC, Najjar S. Risk factors for
development of subclinical hypothyroidism during valproic acid
therapy. J Pediatr. 2007;2:178-81.
11. Brown RS, Huang S. The Thyroid and Its Disorders. Dalam: Brook CG,
Clayton PE, Brown RS, penyunting. Clinical Pediatric Endocrinology.
Edisi ke-5. United Kingdom: Blackwell publishing; 2005.h.218-51.
12. Strolin B, Whomsley R, Baltes E, Tonner F. Alteration of thyroid
hormone homeostasis by antiepileptic drugs in humans: involvement of
glucuronyltransferase induction. Eur J Clin pharmacol. 2005;61:863-
72.
13. Susanto R, J ulia M. Gangguan kelenjar tiroid. Dalam: Batubara J ,
Tridjaja B, Pulungan AB. Buku Ajar Endokrinologi Anak. Edisi ke-1.
J akarta: Badan Penerbit IDAI; 2010.h.205-50.
14. Brown RS, Huang S. The Thyroid Gland. Dalam: Brook CG, Clayton
PE, Brown RS, penyunting. Handbook of Clinical Pediatric
Universitas Sumatera Utara
Endocrinology. Edisi ke-5. United Kingdom: Blackwell publishing;
2008.h.84-98.
15. Camfield PR, Camfield CS. Pediatric epilepsy: an overview. Dalam:
Swaimann KF, Ashwal S, Ferriero VM, penyunting. Pediatric
Neurology Principles & Practice. Edisi ke-1. Philadelphia: Mosby Inc;
2006.h.980-9.
16. Arzimanoglou A, Guerrini R, Aicardi J . Epilepsy: overview and
definitions. Dalam: Arzimanoglou A, Guerrini R, Aicardi J , penyunting.
Aicardis Epilepsy in Children. Edisi ke-3. USA: Maple press; 2004.h.1-
7.
17. Panayiotopoulos CP. Principles of therapy in epilepsies. Dalam:
Panayiotopoulos CP, penyunting. The Epilepsies Seizures, Syndromes
and Management. Edisi ke-1. UK: Bladon medical publishing;
2005.h.59-80.
18. Abaci A, Saygi M, Yis U, Demir K, Dirik E, Bober E. Metabolic
alterations during valproic acid treatment : a prospective study. Pediatr
Neurol. 2009;41:435-9.
19. Arzimanoglou A, Guerrini R, Aicardi J . Medical treatment . Dalam:
Arzimanoglou A, Guerrini R, Aicardi J , penyunting. Aicardis Epilepsy
in Children. Edisi ke-3. USA: Maple press; 2004.h.363-86.
20. Monti B, Polazzi E, Contestabile A. Biochemical, molecular, and
epigenetic mechanism of valproic acid neuroprotection. Curr Mol
Pharmacol. 2009;2:95-109.
21. Thilothammal N, Banu K, Ratnam RS. Comparison of phenobarbitone,
phenytoin with sodium valproate:randomized, double-blind study.
Indian J Pediatr. 1996;33:549-55.
22. Noureen N, Rana MT. Does steady state serum level of valproic acid
correlate with dose, seiure response, and frequency of adverse drug
reactions in Pakistani children with epilepsy?. Pediatric Neurol.
2011;9:333-9.
23. Conway J M, Kriel RL, Birnbaum AK. Antiepileptic drug therapy in
children. Dalam: Swaimann KF, Ashwal S, Ferriero VM, penyunting.
Pediatric Neurology Principles & Practice. Edisi ke-1. Philadelphia:
Mosby Inc; 2006.h.1105-26.
24. Patsalos PN, Berry DJ , Bourgeois BF, Cloyd J C, Glauser TA,
J ohannessen SI, dkk. Antiepileptic drugs-best practice guidelines for
therapeutic drug monitoring: a position paper by the subcommission on
therapeutic drug monitoring, ILAE commission on therapeutic
strategies. Epilepsia. 2008;5:1-38.
25. Kirimi E, Karasalihoglu S, Boz A. Thyroid function in children under
long term administration of antiepileptic drugs. East J Med. 1999;4:23-
6.
26. Verrotti A, Laus M, Scardapane A, Franzoni E, Chiarelli F. Thyroid
hormones in children with epilepsy during long term administration of
carbamazepine and valproate. Eur J Endocrinol. 2009;160:81-6.
Universitas Sumatera Utara
27. Punal Eiris J , Rio-Garma M, Rocamonde S,Rodriguez I, Gago M. Long
term treatment of children with epilepsy with valproate or
carbamazepine may cause subclinical hypothyroidism. Epilepsia.
1999;40:1761-6.
28. Manescu ML, Pakai RM. The influence of the treatment with valproic
acid in the thyroid function in children and adolescents diagnosticated
with epilepsy. J urnalul pediatrului. 2010;13:66-9.
29. Al-J uboori IA, Al-Rawi R, A-Hakeim HK. Estimation of serum copper,
manganese, selenium, and zinc in hypothyroidism patients. Ius J Biol.
2009;68:121-6.
30. Donerat H, Kara IS, Karakoc A, Tan H, Orbak Z. Serum thyroid
hormone profile and trace elements in children receiving valproic acid
therapy: a longintudinal and controlled study. J of Trace Elements in
Medicine and biology. 2012; 26:243-7
31. Vainionpaa LK, Mikkonen K, Rattya J , Knip M, Pakarinen AJ , Isojarvi
J IT, dkk. Thyroid function in girls with epilepsy with carbamazepine,
oxcarbazepine, or valproate monotherapy and after withdrawal of
medication. Epilepsia. 204;45:197-203.
32. Adlin V. Subclinical hypothyroidism: deciding when to treat. Am Fam
Physician. 1998; 57:776-80.
33. Madiyono B, Sastroasmoro S, Moeslichan S, Budiman I, Purwanto SH.
Perkiraan besar sampel. Dalam: Sastroasmoro S, Ismael S,
penyunting. Dasar-Dasar Metodologi Penelitian Klinis. Edisi ke-2.
J akarta: CV Sagung Seto. 2002.h.259-86.
34. George J , J oshi SR. Drugs and thyroid. J Assoc Physicians India.
2007;55:215-23
35. Talebian A, Eslamian MR, Shiasi K, Moravveji A, Khodayari M, Abedi
AR. Changing in thyroid function test in children underwent
antiepileptic therapy. Iran J Child Neurol. 2010; 4:17-22
36. Harsh M, Kumar RY, Asha M, Vivek S. Valproate-induced subclinical
hypothyroidism. Indian J of Forensic Med & Toxicology. 2011; 5:110-2
37. Amirsalari S, Kayhanidost ZT, Kavemanesh Z, Torkman M, Beiraghdar
F, Teimoori M, dkk. Thyroid Function in Epileptic Children who
Receive Carbamazepine, Primidone,Phenobarbital and Valproic Acid.
Iranian J of Child Neurology. 2011; 5(2):15-20
38. Isojrvi J I, Turkka J , Pakarinen AJ , Kotila M, Rtty J , Myllyl VV.
Thyroid Function in Men Taking Carbamazepine, Oxcarbazepine, or
Valproate for Epilepsy. Epilepsia. 2001;42(7):9304
39. Turan MI, Cayir A, Esin IS, Cayir Y, Tan H. Frequency of Subclinic
Hypothyroidism at the patients that are using valproic acid. Diakses
Desember 2013. Diunduh dari: http://www.medicinescience.org
40. Cansu A, Serdaroglu AG, Camurdan O, H rfanoglu T, Aysun Bideci,
Gucuyener A. The evaluation of thyroid functions, thyroid antibodies,
and thyroid volumes in children with epilepsy during short-term
Universitas Sumatera Utara
administration of oxcarbazepine and valproate. Epilepsia. 2006;
47:1855-9
41. Hirfanoglu T, Serdaroglu A, Camurdan O, Cansu A, Bideci A, Cinaz P,
dkk. Thyroid function and volume in epileptic children using
carbamazepine, oxcarbazepine and valproate. Pediatr Int.
2007;49:822-6

















LAMPIRAN

1. Personil Penelitian
Universitas Sumatera Utara